Not Enough Biotech in Your Portfolio?
October 29, 2020 at 07:30 AM EDT
As coronavirus cases start to tick upwards once more, the race to create a vaccine will only intensify, boding well for the biotechnology sector. ETF investors may want to keep an eye on biotech funds, which are already garnering interest as 2020 winds down.